You are here

Working to help find new biomarkers of early liver injury due to medications to prevent liver failure

Description 
Liver injury due to medications is a serious problem and can lead to liver failure and/or interruption to other important therapies (such as cancer therapy). The new checkpoint inhibitors may cause severe liver injury in some patients. This project aims to give the BMedSc (Hons) student interested in Hepatology or Oncololgy, a chance to work with patients at risk of liver injury receiving checkpoint inhibitors for their cancer. The student will be involved in recruiting patients, processing blood samples and sending to research collaborators, collating the results, data analysis and writing up the results.
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
hepatitis, liver failure, drug induced liver injury, biomarkers, immunology
School 
Eastern Health Clinical School
Available options 
PhD/Doctorate
Masters by research
Honours
BMedSc(Hons)
Short projects
Time commitment 
Full-time
Part-time
Top-up scholarship funding available 
No
Physical location 
Department of Gastroenterology, Box Hill
Co-supervisors 
Dr 
Pavel Sluka
Prof 
Dolores Njoku
(External)

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.